SCHEMBL6408488

SCHEMBL6408488

CCOC(=O)CSc1nnc(-c2ccc(OC)cc2)n1-c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.70
HPGD P15428 6/20 0.70
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
LMNA P02545 2/20 0.67
ALPG P10696 1/20 0.66
CDC25A P30304 1/20 0.66
CDC25B P30305 1/20 0.66
MAPT P10636 1/20 0.66
HSD17B10 Q99714 3/20 0.64
TSHR P16473 2/20 0.64
USP2 O75604 1/20 0.64
POLB P06746 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
PKM P14618 1/20 0.62
NPSR1 Q6W5P4 3/20 0.62
TP53 P04637 1/20 0.62
THRB P10828 1/20 0.61
RXFP1 Q9HBX9 1/20 0.61
KDM4E B2RXH2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333083 0.90 MAPT (0.68) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL5332243 0.89 ALDH1A1 (0.67) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6404073 0.89 ALDH1A1 (0.63) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL5331484 0.88 ALDH1A1 (0.66) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6407799 0.88 ALDH1A1 (0.74) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6402656 0.87 ALDH1A1 (0.72) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6403936 0.86 TSHR (0.64) ALDH1A1HPGDMEN1KMT2AALPG
SCHEMBL6402175 0.86 ALDH1A1 (0.60) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL6211327 0.86 CDC25A (0.83) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL14478938 0.83 ALDH1A1 (0.66) ALDH1A1HPGDMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885HPGD 835/4885MEN1 3562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.